Organization
Chungnam National University Hospital
2 clinical trials
1 abstract
Abstract
ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17).Org: Chungbuk Univeristy Hospital, Chungbuk University College of Medicine, Inje University College of Medicine, Pusan National University School of Medicine, Chonnam National University Hwasun Hospital,
Clinical trial
The Effect of Probiotics ATG-F4 in Cancer PatientsStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
mFOLFIRINOX Versus mFOLFOX 6 as Adjuvant Treatment for High Risk Stage III (pT4N1/2 or pTanyN2) Colon Cancer: Multicenter, Open Labeled, Randomized, Phase II StudyStatus: , Estimated PCD: 2025-03-15